Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$781M |
| 2 |
Nike
NKE
|
+$773M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$536M |
| 4 |
Texas Instruments
TXN
|
+$493M |
| 5 |
AGN
Allergan plc
AGN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$1.07B |
| 2 |
Qualcomm
QCOM
|
+$673M |
| 3 |
TJX Companies
TJX
|
+$603M |
| 4 |
NVIDIA
NVDA
|
+$431M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Consumer Discretionary | 17.37% |
| 3 | Healthcare | 13.5% |
| 4 | Communication Services | 13.08% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Trip.com Group
TCOM
$28.2B
| $1.73M | ﹤0.01% |
35,251
-65
| -0.2% | -$2.98K |
|
|
MPG
552
DELISTED
Metaldyne Performance Group Inc.
MPG
| $1.73M | ﹤0.01% |
75,728
-359,211
| -83% | -$8.37M |
|
|
FOMX
553
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.68M | ﹤0.01% |
+340,289
| New | +$3.27M |
|
554
Azenta
AZTA
$1.27B
| $1.64M | ﹤0.01% |
+73,236
| New | +$1.45M |
|
555
Baxter International
BAX
$12.1B
| $1.6M | ﹤0.01% |
30,913
-52,194
| -63% | -$2.57M |
|
556
AMC Entertainment Holdings
AMC
$2.24B
| $1.56M | ﹤0.01% |
+4,972
| New | +$1.59M |
|
557
RBC Bearings
RBC
$18.5B
| $1.46M | ﹤0.01% |
15,020
-667
| -4% | -$61.9K |
|
558
Viavi Solutions
VIAV
$9.41B
| $1.44M | ﹤0.01% |
134,633
+1,245
| +0.9% | +$12.1K |
|
559
Adtran
ADTN
$769M
| $1.43M | ﹤0.01% |
68,942
-15,321
| -18% | -$332K |
|
560
Piper Sandler
PIPR
$5.15B
| $1.4M | ﹤0.01% |
87,396
-3,844
| -4% | -$68K |
|
561
Danaher
DHR
$138B
| $1.32M | ﹤0.01% |
17,442
+6,354
| +57% | +$473K |
|
562
CVS Health
CVS
$137B
| $1.29M | ﹤0.01% |
16,434
-814
| -5% | -$65K |
|
563
Ameris Bancorp
ABCB
$5.77B
| $1.27M | ﹤0.01% |
27,595
-1,230
| -4% | -$56.2K |
|
564
Sociedad Química y Minera de Chile
SQM
$19.6B
| $1.26M | ﹤0.01% |
36,802
+485
| +1% | +$15.8K |
|
565
Provident Financial Services
PFS
$3.11B
| $1.26M | ﹤0.01% |
48,666
+150
| +0.3% | +$3.98K |
|
566
RLI Corp
RLI
$5.88B
| $1.17M | ﹤0.01% |
39,040
-25,964
| -40% | -$769K |
|
|
NAVG
567
DELISTED
Navigators Group Inc
NAVG
| $1.17M | ﹤0.01% |
21,505
-903
| -4% | -$50.4K |
|
568
Progressive
PGR
$125B
| $1.14M | ﹤0.01% |
29,157
-10,673
| -27% | -$407K |
|
|
AMED
569
DELISTED
Amedisys
AMED
| $1.14M | ﹤0.01% |
22,240
-9,985
| -31% | -$476K |
|
570
JD.com
JD
$41.8B
| $1.13M | ﹤0.01% |
36,192
-160
| -0.4% | -$4.71K |
|
|
HF
571
DELISTED
HFF Inc.
HF
| $1.03M | ﹤0.01% |
37,399
-1,633
| -4% | -$47.9K |
|
|
TBI
572
Trueblue
TBI
$237M
| $1.03M | ﹤0.01% |
37,605
-483,829
| -93% | -$12.3M |
|
573
PUT
iShares Biotechnology ETF
IBB
$9.44B
| $1.01M | ﹤0.01% |
10,299
-52,848
| -84% | -$5.06M |
|
574
FTI Consulting
FCN
$4.88B
| $995K | ﹤0.01% |
24,179
-1,056
| -4% | -$43.8K |
|
|
B
575
DELISTED
Barnes Group Inc.
B
| $993K | ﹤0.01% |
19,338
+99
| +0.5% | +$4.85K |
|
Similar funds
Jennison Associates's Q1 2017 Portfolio in Review
As of Q1 2017, Jennison Associates held 861 positions worth $93.2B, up 4.1% from $89.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jennison Associates withdrew a net $4.47B in Q1 2017, closing 224 positions and reducing 376 holdings. Its most notable exit was Mobileye N.V., an estimated $165M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Snap worth $119M.
- Jennison Associates's largest Q1 2017 buy was Snap: 5,289,727 shares worth $119M.
- Jennison Associates added most to Broadcom in Q1 2017, an estimated $781M increase.
- Jennison Associates's biggest Q1 2017 reduction was Starbucks, cutting an estimated $1.07B.
- Jennison Associates fully exited Mobileye N.V. in Q1 2017, selling an estimated $165M.
- Jennison Associates's ten largest holdings make up 26% of its $93.2B portfolio in Q1 2017.
- Jennison Associates opened 55 new positions and closed 224 in Q1 2017.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $93.2B.
Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.